Dryness & GSM faq

Do dilators help painful sex caused by GSM?

Yes—vaginal dilators can help when painful sex (dyspareunia) is driven by genitourinary syndrome of menopause (GSM), especially if pelvic floor muscles have become over-protective. They work best alongside a scheduled vaginal moisturiser, a suitable lubricant, and often local vaginal oestrogen or DHEA. Progress is gradual, comfort-first, and personalised—ideally with pelvic health physiotherapy guidance. Educational only. Results vary. Not a cure.

Clinical Context

Who may suit dilators? Those with GSM and entrance-dominant dyspareunia, micro-tears, or speculum intolerance; people whose pelvic floor is persistently tense; and anyone rebuilding confidence after pain. Combine with a scheduled moisturiser, ample lubricant, and—when dryness is intrusive—local vaginal oestrogen or DHEA. If systemic HRT helps flushes but dryness persists, local therapy is usually still required.

Who should seek review first? Anyone with post-menopausal bleeding, new ulcers/rapidly changing white plaques (possible dermatoses such as lichen sclerosus), malodorous or green/grey discharge, fever or severe pelvic pain, or visible blood in urine. Treat proven infections (thrush/BV/UTI) before continuing rehabilitation. If deep pain persists despite good surface comfort, investigate other pelvic drivers.

Next steps. Plan a 6–12-week check-in to review technique, adjust sizes, and reduce to the lowest effective maintenance once comfortable. Keep intimacy paced and pleasure-led. Consider psychosexual therapy if fear-avoidance lingers despite tissue and muscle improvements.

Evidence-Based Approaches

Guidelines & patient resources. NHS pages outline self-care and when to seek help for painful sex (dyspareunia) and vaginal dryness. The NICE menopause guideline (NG23) recommends vaginal moisturisers/lubricants first-line and considering low-dose local vaginal oestrogen for GSM when symptoms affect quality of life; local therapy can be used with or without systemic HRT. RCOG’s patient information on vulval pain discusses pelvic floor over-activity and conservative management.

Reviews & trials. Cochrane reviews report that local oestrogens improve dryness, soreness, dyspareunia and vaginal pH versus placebo across creams, pessaries/tablets and rings—useful when non-hormonal measures are insufficient (Cochrane Library). Evidence for dilators in GSM-related dyspareunia largely comes from pelvic floor and vulvodynia rehabilitation literature: controlled studies and systematic reviews summarised on PubMed describe benefits of pelvic floor physical therapy and graded dilator work in reducing pain and improving sexual function through down-training and desensitisation.

Applying the evidence. Treat GSM biology (moisturiser ± local oestrogen/DHEA), address pelvic floor over-activity (physio-led down-training and graded dilators), and maintain ample lubrication for intimacy. This combined pathway aligns with NHS/NICE/RCOG guidance and the rehabilitation evidence base for dyspareunia/vestibulodynia.